MeSH term
Frequency | Condition_Probility | Adult | 5 | 0.0 |
Aged | 4 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Alleles | 4 | 0.0 |
Cell Cycle | 2 | 0.0 |
Codon | 2 | 0.0 |
Exons | 2 | 0.0 |
Homozygote | 3 | 0.0 |
Humans | 16 | 0.0 |
Loss of Heterozygosity | 3 | 0.0 |
Middle Aged | 4 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 15 | 0.0 |
*Cell Cycle Proteins | 7 | 0.0 |
Enzyme Inhibitors | 2 | 2.0 |
*Gene Deletion | 3 | 0.0 |
*Genes, Tumor Suppressor | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 3 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Base Sequence | 4 | 0.0 |
Cyclin-Dependent Kinases/*genetics | 2 | 3.0 |
*Genes, p16 | 2 | 2.0 |
Genes, p53/*genetics | 2 | 0.0 |
Melanoma/*genetics | 2 | 1.0 |
Molecular Sequence Data | 4 | 0.0 |
Polymorphism, Single-Stranded Conformational | 2 | 0.0 |
*Proto-Oncogene Proteins | 2 | 0.0 |
Gene Expression Profiling | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Male | 7 | 0.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Carrier Proteins/*genetics | 6 | 0.0 |
Child | 2 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Cyclins/*genetics | 3 | 2.0 |
*Enzyme Inhibitors | 6 | 15.0 |
Female | 6 | 0.0 |
*Tumor Suppressor Proteins | 6 | 0.0 |
Adolescent | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Comparative Study | 2 | 0.0 |
Brain Neoplasms/*genetics/pathology | 2 | 2.0 |
Oligodendroglioma/*genetics/pathology | 2 | 16.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Child, Preschool | 3 | 0.0 |
